Shopping Cart 0
Cart Subtotal
USD 0

Medicure Inc (MPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750

Details

Summary

Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company's product portfolio comprises Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndrome including unstable angina; and Zypitamag, to treat patients suffering from primary hyperlipidemia or mixed dyslipidemia. It is also developing Tardoxal, a small molecule drug for the treatment of neurological conditions such as tardive dyskinesia. The company works in collaboration with CRO's and pharmaceutical companies to develop and commercialize its product portfolio. It has operations in Canada, the US and Barbados. Medicure is headquartered in Winnipeg, Manitoba, Canada.

Medicure Inc (MPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicure Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Zydus Cadila Healthcare to Enter into Agreement with Medicure International 10

Medicure International Enters into Co-Development Agreement with Apicore 11

4P Therapeutics Enters into Partnership with Medicure 12

Licensing Agreements 13

Medicure Enters into Licensing Agreement with Pharmaceutical Company 13

Medicure International Enters into Licensing Agreement with Carmel Biosciences 14

Equity Offering 15

Medicure Raises USD3.3 Million in Bought Deal Private Placement of Shares 15

Acquisition 16

Medicure Sells Majority Stake in Apicore 16

Medicure Acquires Additional Stake in Apicore for USD24.5 Million 18

Medicure Acquires Majority Stake in Apicore for USD33.25 Million 19

Medicure Acquires 6.09% Equity Stake in Apicore, Pharma Manufacturer 20

Medicure Inc-Key Competitors 21

Medicure Inc-Key Employees 22

Medicure Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 15, 2018: Medicure announces financial results for quarter ended June 30, 2018 24

May 23, 2018: Medicure Reports Financial Results for Quarter Ended March 31, 2018 25

May 01, 2018: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017 26

Aug 07, 2017: Medicure Reports Financial Results for Quarter Ended June 30, 2017 27

May 24, 2017: Medicure Reports Financial Results for Quarter Ended March 31, 2017 28

Apr 26, 2017: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016 29

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Medicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicure Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Medicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Zydus Cadila Healthcare to Enter into Agreement with Medicure International 10

Medicure International Enters into Co-Development Agreement with Apicore 11

4P Therapeutics Enters into Partnership with Medicure 12

Medicure Enters into Licensing Agreement with Pharmaceutical Company 13

Medicure International Enters into Licensing Agreement with Carmel Biosciences 14

Medicure Raises USD3.3 Million in Bought Deal Private Placement of Shares 15

Medicure Sells Majority Stake in Apicore 16

Medicure Acquires Additional Stake in Apicore for USD24.5 Million 18

Medicure Acquires Majority Stake in Apicore for USD33.25 Million 19

Medicure Acquires 6.09% Equity Stake in Apicore, Pharma Manufacturer 20

Medicure Inc, Key Competitors 21

Medicure Inc, Key Employees 22

Medicure Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Medicure Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company's product portfolio comprises Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndrome including unstable angina; and Zypitamag, to treat patients suffering from primary hyperlipidemia or mixed dyslipidemia. It is also developing Tardoxal, a small molecule drug for the treatment of neurological conditions such as tardive dyskinesia. The company works in collaboration with CRO's and pharmaceutical companies to develop and commercialize its product portfolio. It has operations in Canada, the US and Barbados. Medicure is headquartered in Winnipeg, Manitoba, Canada.

Medicure Inc (MPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicure Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Zydus Cadila Healthcare to Enter into Agreement with Medicure International 10

Medicure International Enters into Co-Development Agreement with Apicore 11

4P Therapeutics Enters into Partnership with Medicure 12

Licensing Agreements 13

Medicure Enters into Licensing Agreement with Pharmaceutical Company 13

Medicure International Enters into Licensing Agreement with Carmel Biosciences 14

Equity Offering 15

Medicure Raises USD3.3 Million in Bought Deal Private Placement of Shares 15

Acquisition 16

Medicure Sells Majority Stake in Apicore 16

Medicure Acquires Additional Stake in Apicore for USD24.5 Million 18

Medicure Acquires Majority Stake in Apicore for USD33.25 Million 19

Medicure Acquires 6.09% Equity Stake in Apicore, Pharma Manufacturer 20

Medicure Inc-Key Competitors 21

Medicure Inc-Key Employees 22

Medicure Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 15, 2018: Medicure announces financial results for quarter ended June 30, 2018 24

May 23, 2018: Medicure Reports Financial Results for Quarter Ended March 31, 2018 25

May 01, 2018: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017 26

Aug 07, 2017: Medicure Reports Financial Results for Quarter Ended June 30, 2017 27

May 24, 2017: Medicure Reports Financial Results for Quarter Ended March 31, 2017 28

Apr 26, 2017: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016 29

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Medicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicure Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicure Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Medicure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Zydus Cadila Healthcare to Enter into Agreement with Medicure International 10

Medicure International Enters into Co-Development Agreement with Apicore 11

4P Therapeutics Enters into Partnership with Medicure 12

Medicure Enters into Licensing Agreement with Pharmaceutical Company 13

Medicure International Enters into Licensing Agreement with Carmel Biosciences 14

Medicure Raises USD3.3 Million in Bought Deal Private Placement of Shares 15

Medicure Sells Majority Stake in Apicore 16

Medicure Acquires Additional Stake in Apicore for USD24.5 Million 18

Medicure Acquires Majority Stake in Apicore for USD33.25 Million 19

Medicure Acquires 6.09% Equity Stake in Apicore, Pharma Manufacturer 20

Medicure Inc, Key Competitors 21

Medicure Inc, Key Employees 22

Medicure Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Medicure Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.